{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:14:36Z","timestamp":1788408876029,"version":"build-2803163510"},"reference-count":135,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2022-67015-36335"],"award-info":[{"award-number":["2022-67015-36335"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001655","name":"Grayson Jockey Club Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001655","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Link Equine Research Endowment"},{"DOI":"10.13039\/100007904","name":"Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["SCR_022169"],"award-info":[{"award-number":["SCR_022169"]}],"id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020809","name":"Eterna Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013674","name":"College of Veterinary Medicine and Biomedical Sciences, Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015581","name":"Houston Methodist Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015581","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Glenn Blodgett Chair in Equine Studies"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.06.025","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T11:04:09Z","timestamp":1749899049000},"page":"4175-4192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi"],"prefix":"10.1016","volume":"33","author":[{"given":"Rebecca M.","family":"Legere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine A.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryll","family":"Vanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.R.","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae","family":"Yeon Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana P.","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne M.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Landrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Chistensen","family":"Blazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Benham-Duret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Mistretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia R.","family":"Woolums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Criscitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc R.","family":"Berghman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela I.","family":"Bordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Pollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-2903","authenticated-orcid":false,"given":"Noah D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.025_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/evj.13567","article-title":"Rhodococcus equi foal pneumonia: Update on epidemiology, immunity, treatment and prevention","volume":"54","author":"Bordin","year":"2022","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.ymthe.2025.06.025_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cveq.2014.08.010","article-title":"Rhodococcus equi foal pneumonia","volume":"30","author":"Cohen","year":"2014","journal-title":"Vet. Clin. North Am. Equine Pract."},{"key":"10.1016\/j.ymthe.2025.06.025_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01537-23","article-title":"Rhodococcus infection: a 10-year retrospective analysis of clinical experience and antimicrobial susceptibility profile","volume":"62","author":"Ranganath","year":"2024","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/lam.13386","article-title":"Reinvestigation of the virulence of Rhodococcus equi isolates from patients with and without AIDS","volume":"71","author":"Takai","year":"2020","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/apc.2009.0248","article-title":"Rhodococcus equi infection in HIV-infected individuals: case reports and review of the literature","volume":"24","author":"Topino","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ymthe.2025.06.025_bib6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/clinids\/5.6.1012","article-title":"Corynebacterium equi: a review of 12 cases of human infection","volume":"5","author":"Van Etta","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.06.025_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2737295","article-title":"Differences in Rhodococcus equi infections based on immune status and antibiotic susceptibility of clinical isolates in a case series of 12 patients and cases in the literature","volume":"2016","author":"Gundelly","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.06.025_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190829","article-title":"Detection of vapN in Rhodococcus equi isolates cultured from humans","volume":"13","author":"Bryan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.025_bib9","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/iai.60.7.2995-2997.1992","article-title":"Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens","volume":"60","author":"Takai","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib10","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/IAI.67.7.3548-3557.1999","article-title":"Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi","volume":"67","author":"Gigu\u00e8re","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vetmic.2013.09.018","article-title":"The effect of bacterial dose and foal age at challenge on Rhodococcus equi infection","volume":"167","author":"Sanz","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib12","first-page":"171","article-title":"Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection","volume":"15","author":"Horowitz","year":"2001","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-2427(03)00021-7","article-title":"Temporal changes in cytokine expression of foals during the first month of life","volume":"92","author":"Boyd","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1939-1676.1999.tb02180.x","article-title":"Peripheral blood lymphocyte subpopulations and immunoglobulin concentrations in healthy foals and foals with Rhodococcus equi pneumonia","volume":"13","author":"Flaminio","year":"1999","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-2427(00)00149-5","article-title":"Characterization of peripheral blood and pulmonary leukocyte function in healthy foals","volume":"73","author":"Flaminio","year":"2000","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vetimm.2008.10.004","article-title":"Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro","volume":"127","author":"Nerren","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.vaccine.2008.11.040","article-title":"Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals","volume":"27","author":"Liu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.06.025_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2009.03.002","article-title":"Young foal and adult horse monocyte-derived dendritic cells differ by their degree of phenotypic maturity","volume":"131","author":"M\u00e9rant","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vetimm.2018.11.020","article-title":"The effect of age on foal monocyte-derived dendritic cell (MoDC) maturation and function after exposure to killed bacteria","volume":"210","author":"Lopez","year":"2019","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib20","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/CVI.00328-10","article-title":"Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses","volume":"17","author":"Ryan","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib21","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2460\/javma.1994.204.10.1644","article-title":"Causes of and farm management factors associated with disease and death in foals","volume":"204","author":"Cohen","year":"1994","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ymthe.2025.06.025_bib22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2460\/javma.2003.223.1791","article-title":"Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection","volume":"223","author":"Chaffin","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ymthe.2025.06.025_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2460\/javma.1998.213.04.510","article-title":"Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992)","volume":"213","author":"Ainsworth","year":"1998","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ymthe.2025.06.025_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250133","article-title":"Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence-associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia","volume":"16","author":"Kahn","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.025_bib25","first-page":"571","article-title":"Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma","volume":"44","author":"Madigan","year":"1991","journal-title":"J. Reprod. Fertil. Suppl."},{"key":"10.1016\/j.ymthe.2025.06.025_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.2042-3306.1989.tb02161.x","article-title":"Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals","volume":"21","author":"Martens","year":"1989","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.ymthe.2025.06.025_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/vr.102594","article-title":"Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals","volume":"175","author":"Sanz","year":"2014","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ymthe.2025.06.025_bib28","first-page":"361","article-title":"Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals","volume":"7","author":"Caston","year":"2006","journal-title":"Vet. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/vr.103095","article-title":"Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals","volume":"178","author":"Sanz","year":"2016","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ymthe.2025.06.025_bib30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2460\/ajvr.2001.62.1307","article-title":"Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia","volume":"62","author":"Hooper-McGrevy","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib31","first-page":"641","article-title":"Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms","volume":"46","author":"Higuchi","year":"1999","journal-title":"Zentralbl. Veterinarmed. B"},{"key":"10.1016\/j.ymthe.2025.06.025_bib32","article-title":"Protective immune responses against Rhodococcus equi : an innate immunity-focused review","volume":"497","author":"Bordin","year":"2024","journal-title":"ESS Open Archive eprints"},{"key":"10.1016\/j.ymthe.2025.06.025_bib33","first-page":"345","article-title":"Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins","volume":"10","author":"Hooper-McGrevy","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007160","article-title":"Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi","volume":"14","author":"Cywes-Bentley","year":"2018","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.06.025_bib35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2019.01.028","article-title":"PNAG-specific equine IgG(1) mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG(4\/7)","volume":"37","author":"Rocha","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.06.025_bib36","first-page":"1","article-title":"Serum activities of complement 1q and antibodies to the virulence-associated protein A are lower in foals that develop rhodococcal pneumonia","volume":"13","author":"Bettencourt","year":"2024","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/evj.13858","article-title":"Transfusion of hyperimmune plasma for protecting foals against Rhodococcus equi pneumonia","volume":"55","author":"Kahn","year":"2023","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.ymthe.2025.06.025_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/evj.12310","article-title":"Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development","volume":"47","author":"Giles","year":"2015","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.ymthe.2025.06.025_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1135(97)00089-8","article-title":"Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines","volume":"56","author":"Varga","year":"1997","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetmic.2004.09.006","article-title":"Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine","volume":"104","author":"Cauchard","year":"2004","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00638-21","article-title":"Serum antibody activity against poly-N-acetyl glucosamine (PNAG), but not PNAG vaccination status, is associated with protecting newborn foals against intrabronchial infection with Rhodococcus equi","volume":"9","author":"Cohen","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ymthe.2025.06.025_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1135(97)00088-6","article-title":"Immunoprophylaxis of Rhodococcus equi pneumonia in foals","volume":"56","author":"Bec\u00fa","year":"1997","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03372-20","article-title":"The principles of antibody therapy for infectious diseases with relevance for COVID-19","volume":"12","author":"Casadevall","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2025.06.025_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40794-023-00212-x","article-title":"Monoclonal antibody applications in travel medicine","volume":"10","author":"de Jong","year":"2024","journal-title":"Trop. Dis. Trav. Med. Vaccin."},{"key":"10.1016\/j.ymthe.2025.06.025_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12967-019-1804-8","article-title":"How mRNA therapeutics are entering the monoclonal antibody field","volume":"17","author":"Van Hoecke","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00018-018-2935-4","article-title":"mRNA as novel technology for passive immunotherapy","volume":"76","author":"Schlake","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.06.025_bib47","article-title":"Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination","volume":"38","author":"Hodgson","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.ymthe.2025.06.025_bib48","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41591-023-02316-5","article-title":"Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants","volume":"29","author":"Wilkins","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.ymthe.2025.06.025_bib50","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jac\/dkad076","article-title":"Nirsevimab: review of pharmacology, antiviral activity and emerging clinical experience for respiratory syncytial virus infection in infants","volume":"78","author":"Jorgensen","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ymthe.2025.06.025_bib51","article-title":"Expanding the reach of monoclonal antibodies: A review of synthetic nucleic acid delivery in immunotherapy","volume":"12","author":"Chung","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.ymthe.2025.06.025_bib52","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.15252\/emmm.201707678","article-title":"mRNA mediates passive vaccination against infectious agents, toxins, and tumors","volume":"9","author":"Thran","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.4356","article-title":"Elimination of large tumors in mice by mRNA-encoded bispecific antibodies","volume":"23","author":"Stadler","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib55","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/s41467-018-06508-3","article-title":"Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection","volume":"9","author":"Tiwari","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ymthe.2020.01.002","article-title":"Aerosol delivery of synthetic mRNA to vaginal mucosa leads to durable expression of broadly neutralizing antibodies against HIV","volume":"28","author":"Lindsay","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.omtn.2020.04.015","article-title":"mRNA encoding a bispecific single domain antibody construct protects against Influenza A virus infection in mice","volume":"20","author":"Van Hoecke","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.06.025_bib58","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.ymthe.2024.05.036","article-title":"In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection","volume":"32","author":"Tkaczyk","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2358570","article-title":"Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis","volume":"20","author":"Qiaerxie","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2025.06.025_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae100","article-title":"Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau","volume":"6","author":"Wongsodirdjo","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-024-01766-8","article-title":"Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses","volume":"9","author":"Chi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib62","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acs.molpharmaceut.3c01016","article-title":"Pharmacokinetic analyses of a lipid nanoparticle-encapsulated mRNA-encoded antibody against Rift Valley Fever virus","volume":"21","author":"Wang","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.06.025_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01612-22","article-title":"A single dose of anti-HBsAg antibody-encoding mRNA-LNPs suppressed HBsAg expression: A potential cure of chronic hepatitis B virus infection","volume":"13","author":"Chen","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2025.06.025_bib64","article-title":"Advancements in mRNA encoded antibodies for passive immunotherapy","volume":"9","author":"Deal","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.06.025_bib65","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ymthe.2019.03.002","article-title":"mRNA: A novel avenue to antibody therapy?","volume":"27","author":"Schlake","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s12967-023-04553-1","article-title":"Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40259-020-00412-3","article-title":"In vivo delivery of nucleic acid-encoded monoclonal antibodies","volume":"34","author":"Patel","year":"2020","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2025.06.025_bib68","article-title":"An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions","volume":"4","author":"Deal","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib69","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","article-title":"A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus","volume":"27","author":"August","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib70","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.06.025_bib71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41563-022-01404-0","article-title":"Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung","volume":"22","author":"Rotolo","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ymthe.2025.06.025_bib72","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.06.025_bib73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.copbio.2021.10.017","article-title":"Inhalable mRNA vaccines for respiratory diseases: a roadmap","volume":"74","author":"Roh","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib74","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Recent progress in nucleic acid pulmonary delivery toward overcoming physiological barriers and improving transfection efficiency","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.06.025_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202771","article-title":"Nebulized mRNA-encoded antibodies protect hamsters from SARS-CoV-2 infection","volume":"9","author":"Vanover","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.06.025_bib76","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkh412","article-title":"IMGT\/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis","volume":"32","author":"Giudicelli","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib77","doi-asserted-by":"crossref","DOI":"10.2460\/ajvr.23.09.0208","article-title":"Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals","volume":"85","author":"Legere","year":"2024","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105367","article-title":"Immunogenicity of an electron beam inactivated Rhodococcus equi vaccine in neonatal foals","volume":"9","author":"Bordin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.025_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/infdis\/jiz068","article-title":"In vitro characterization and in vivo effectiveness of Ebola virus specific equine polyclonal F(ab')2","volume":"220","author":"Racine","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.06.025_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66657-8","article-title":"A pan-specific antiserum produced by a novel immunization strategy shows a high spectrum of neutralization against neurotoxic snake venoms","volume":"10","author":"Ratanabanangkoon","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.025_bib81","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.vaccine.2016.04.086","article-title":"Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use","volume":"34","author":"Korimbocus","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.06.025_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012187","article-title":"Comparison of the intrageneric neutralization scope of monospecific, bispecific\/monogeneric and polyspecific\/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms","volume":"18","author":"S\u00e1nchez","year":"2024","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2025.06.025_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090528","article-title":"Antibodies and vaccines against botulinum toxins: Available measures and novel approaches","volume":"11","author":"Rasetti-Escargueil","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ymthe.2025.06.025_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/antib12040080","article-title":"Neutralization of different variants of SARS-CoV-2 by a F(ab')2 preparation from sera of horses immunized with the viral receptor binding domain","volume":"12","author":"Rodriguez-Nu\u00f1ez","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.ymthe.2025.06.025_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.942317","article-title":"Centaur antibodies: Engineered chimeric equine-human recombinant antibodies","volume":"13","author":"Rosenfeld","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/v14102172","article-title":"Exploiting V-gene bias for rapid, high-throughput monoclonal antibody isolation from horses","volume":"14","author":"Wibmer","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.06.025_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41467-023-44534-y","article-title":"Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability","volume":"15","author":"Gorman","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib88","article-title":"A customizable suite of methods to sequence and annotate cattle antibodies","volume":"11","author":"Ramirez Valdez","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.06.025_bib89","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.2100824","article-title":"Single-cell-based high-throughput Ig and TCR repertoire sequencing analysis in Rhesus macaques","volume":"208","author":"Walsh","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib90","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.it.2021.10.008","article-title":"Single B cell technologies for monoclonal antibody discovery","volume":"42","author":"Pedrioli","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib91","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s42003-019-0551-y","article-title":"Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies","volume":"2","author":"Goldstein","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib92","article-title":"Development of porcine monoclonal antibodies with in vitro neutralizing activity against Classical Swine Fever virus from C-strain E2-specific single B cells","volume":"15","author":"Wang","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.06.025_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177831","article-title":"Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate","volume":"12","author":"Tallmadge","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.025_bib94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molimm.2018.11.017","article-title":"Next-generation sequencing reveals new insights about gene usage and CDR-H3 composition in the horse antibody repertoire","volume":"105","author":"Manso","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1439-0442.1996.tb00489.x","article-title":"Immunohistochemical examination of light-chain expression (lambda\/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells","volume":"43","author":"Arun","year":"1996","journal-title":"Zentralbl. Veterinarmed. A."},{"key":"10.1016\/j.ymthe.2025.06.025_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.dci.2014.04.001","article-title":"Diversity of immunoglobulin lambda light chain gene usage over developmental stages in the horse","volume":"46","author":"Tallmadge","year":"2014","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib97","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molimm.2007.06.158","article-title":"The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies","volume":"45","author":"Lewis","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib98","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2460\/ajvr.2000.61.1099","article-title":"Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses","volume":"61","author":"Sheoran","year":"2000","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.06.025_bib100","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","article-title":"High-throughput mapping of B cell receptor sequences to antigen specificity","volume":"179","author":"Setliff","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.06.025_bib101","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1038\/s41467-019-11049-4","article-title":"High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes","volume":"10","author":"Singh","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":"Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities","volume":"13","author":"Xu","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.06.025_bib103","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/17460441.2021.1935859","article-title":"An overview of rational design of mRNA-based therapeutics and vaccines","volume":"16","author":"To","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.06.025_bib104","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.025_bib105","doi-asserted-by":"crossref","first-page":"eaaz6893","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.06.025_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114961","article-title":"Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics","volume":"199","author":"Kang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.06.025_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.06.025_bib108","article-title":"Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2025.06.025_bib109","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2023.12.012","article-title":"Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol","volume":"366","author":"Neary","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.06.025_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5358272","article-title":"Posttranslational modifications and the immunogenicity of biotherapeutics","volume":"2016","author":"Jefferis","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib111","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12033-008-9049-4","article-title":"Post-translational modifications of recombinant proteins: significance for biopharmaceuticals","volume":"39","author":"Jenkins","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.025_bib112","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2144\/btn-2019-0054","article-title":"Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications","volume":"67","author":"Zaroff","year":"2019","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2025.06.025_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137504","article-title":"Nebulisation of IVT mRNA complexes for intrapulmonary administration","volume":"10","author":"Johler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.025_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10580","article-title":"Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles","volume":"8","author":"Lewis","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.025_bib115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.06.025_bib116","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.06.025_bib117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/vetsci10010020","article-title":"Local and systemic antibody responses in beef calves vaccinated with a modified-live virus bovine respiratory syncytial virus (BRSV) vaccine at birth following BRSV infection","volume":"10","author":"Mart\u00ednez","year":"2022","journal-title":"Vet. Sci."},{"key":"10.1016\/j.ymthe.2025.06.025_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/ajvr.22.07.0118","volume":"83","author":"Mart\u00ednez","year":"2022","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib119","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-023-29234-3","article-title":"NMR-based metabolomics of plasma from dairy calves infected with two primary causal agents of bovine respiratory disease (BRD)","volume":"13","author":"Santos-Rivera","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.025_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphys.2021.111192","article-title":"Degradation of lipid based drug delivery formulations during nebulization","volume":"547","author":"Klein","year":"2021","journal-title":"Chem. Phys."},{"key":"10.1016\/j.ymthe.2025.06.025_bib121","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1038\/s41598-023-35872-4","article-title":"Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery","volume":"13","author":"van Rijn","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.025_bib122","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41598-020-79855-1","article-title":"Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent","volume":"11","author":"Legere","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.025_bib123","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.theriogenology.2017.04.027","article-title":"Effects of season on placental, foetal and neonatal development in horses","volume":"97","author":"Beythien","year":"2017","journal-title":"Theriogenology"},{"key":"10.1016\/j.ymthe.2025.06.025_bib124","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10439-017-1971-9","article-title":"Airflow simulations in infant, child, and adult pulmonary conducting airways","volume":"46","author":"Oakes","year":"2018","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.06.025_bib125","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1038\/s41467-023-43798-8","article-title":"A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection","volume":"14","author":"Tai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib126","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2005.07.050","article-title":"Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi","volume":"23","author":"Hooper-McGrevy","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.06.025_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00383-23","article-title":"Impact of surface receptors TLR2, CR3, and Fc\u03b3RIII on Rhodococcus equi phagocytosis and intracellular survival in macrophages","volume":"92","author":"da Silveira","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2025.06.025_bib128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1746-6148-7-26","article-title":"Growth and differentiation of primary and passaged equine bronchial epithelial cells under conventional and air-liquid-interface culture conditions","volume":"7","author":"Abraham","year":"2011","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11626-008-9099-8","article-title":"Isolation and culture of primary equine tracheal epithelial cells","volume":"44","author":"Shibeshi","year":"2008","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.ymthe.2025.06.025_bib130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2460\/ajvr.68.1.63","article-title":"Evaluation of fecal samples from mares as a source of Rhodococcus equi for their foals by use of quantitative bacteriologic culture and colony immunoblot analyses","volume":"68","author":"Grimm","year":"2007","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2460\/ajvr.72.1.73","article-title":"Effects of location for collection of air samples on a farm and time of day of sample collection on airborne concentrations of virulent Rhodococcus equi at two horse breeding farms","volume":"72","author":"Kuskie","year":"2011","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib132","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2460\/ajvr.73.10.1603","article-title":"Association of airborne concentration of virulent Rhodococcus equi with location (stall versus paddock) and month (January through June) on 30 horse breeding farms in central Kentucky","volume":"73","author":"Cohen","year":"2012","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.06.025_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012345","article-title":"mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNA","volume":"20","author":"Chaves","year":"2024","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.06.025_bib134","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/ajrccm\/141.1.208","article-title":"Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples","volume":"141","author":"Rennard","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ymthe.2025.06.025_bib135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-991520","article-title":"Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure","volume":"28","author":"Baughman","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:40:39Z","timestamp":1788406839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":135,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525001625004769"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}